Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis.
Journal of Drugs in Dermatology: JDD, 2017 - europepmc.org
OBJECTIVE: To examine real-world use and patient outcomes with apremilast, an oral
PDE4 inhibitor, in the dermatology practice set-ting for treatment of patients with moderate to …
PDE4 inhibitor, in the dermatology practice set-ting for treatment of patients with moderate to …
Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis
A Armstrong, E Levi - Journal of drugs in dermatology …, 2017 - pubmed.ncbi.nlm.nih.gov
OBJECTIVE: To examine real-world use and patient outcomes with apremilast, an oral
PDE4 inhibitor, in the dermatology practice set-ting for treatment of patients with moderate to …
PDE4 inhibitor, in the dermatology practice set-ting for treatment of patients with moderate to …